Pelubiprofen

Pelubiprofen
Clinical data
Trade names	Pelubi
ATC code	M01AE20 (WHO) ;
Legal status
Legal status	Rx in several countries;
Identifiers
	IUPAC name 2-[4-[(E)-(2-Oxocyclohexylidene)methyl]phenyl]propanoic acid;
CAS Number	69956-77-0;
PubChem CID	5282203;
DrugBank	DB12150;
UNII	1619C79FVJ;
CompTox Dashboard (EPA)	DTXSID2048795 ;
Chemical and physical data
Formula	C16H18O3
Molar mass	258.317 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C1=CC=C(C=C1)/C=C/2\CCCCC2=O)C(=O)O;
	InChI InChI=1S/C16H18O3/c1-11(16(18)19)13-8-6-12(7-9-13)10-14-4-2-3-5-15(14)17/h6-11H,2-5H2,1H3,(H,18,19)/b14-10+; Key:AUZUGWXLBGZUPP-GXDHUFHOSA-N;

Pelubiprofen is a nonsteroidal anti-inflammatory drug of the profen class used to treat back pain and osteoarthritis.

Pelubiprofen was developed in South Korea by Daewon Pharmaceuticals and it is marketed in Korea and Russia, among other countries.